Delivery Order SPE2DB20D3101-SPE2DB25FRWS4
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90-day supplies at a ceiling value of $18,287.44. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $2,430.48 by the Defense Logistics Agency on September 8, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count packages). The contract carries a firm fixed price structure with an ultimate completion date of September 9, 2025, and represents a non-set-aside award. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.97 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on September 10, 2025, with completion scheduled for September 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Losartan-HCTZ 100-25 mg tablets in a 90-day quantity, valued at $8,843.11. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,851.36 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity. This competitively awarded, firm fixed-price contract is categorized as a delivery order with an ultimate completion date of September 17, 2025, and carries no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,456.18 delivery order on August 14, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count). This competitive award utilized firm fixed price contracting with no set-aside designation and an ultimate completion date of August 15, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.45 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This award represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $2,934.36 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on September 16, 2025. This firm fixed price delivery order, with a completion date of September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) valued at $9,377.10. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement for pharmaceutical supplies supporting military and federal healthcare systems. The contract requires completion by September 18, 2025, with performance at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,491.29 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order represents a child...